Seattle Children’s Opens First CAR T-Cell Immunotherapy Trial in the US for Children and Young Adults With Leukemia … – PR Newswire (press release)
GeekWire |
Seattle Children's Opens First CAR T-Cell Immunotherapy Trial in the US for Children and Young Adults With Leukemia …
PR Newswire (press release) SEATTLE, Nov. 16, 2017 /PRNewswire-USNewswire/ — Seattle Children's has opened the first chimeric antigen receptor (CAR) T-cell immunotherapy trial in the U.S. for children and young adults with relapsed or refractory CD19- and CD22-positive acute … New immunotherapy study aims to prevent children with leukemia from relapsing |
